KMT2A and acute myeloid leukemia: In the human MLL-AF9 AML cell line THP-1, LIN28B knockdown resulted in a significant reduction in tumor burden in an AML xenograft model, resulting from de-repression of let-7, which in turn regulated another RBP, IGF2BP1 [120].